protein

Recombinant Human Angiopoietin-like 2 Protein, CF

9746-AN-025/CF

25 ug

578 USD

9746-AN/CF

9746-AN-025/CF

Recombinant Human Angiopoietin-like 2 Protein, CF

25 ug

The Recombinant Human Angiopoietin-like 2 Protein, CF from R&D Systems is derived from NS0. The Recombinant Human Angiopoietin-like 2 Protein, CF has been validated for the following applications: Bioactivity.

Angiopoietin-like Protein 2/ANGPTL2

Proteins and Enzymes

Lyophilized from a 0.2 ╡m filtered solution in Tris, NaCl and CHAPS with Trehalose.

Unconjugated

Bioactivity

>75%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie« Blue Staining.

Human

60-69 kDa, reducing conditions

56 kDa

Measured by its binding ability in a functional ELISA. When Recombinant Angiopoietin-like Protein 2/ANGPTL2 is coated at 2 ╡g/mL, Recombinant Human LILRB2/CD85d/ILT4 Fc Chimera (Catalog # 2078-T4 ) binds with an ED50 of 0.02-0.12 ╡g/mL Measured by its ability to promote the expansion of E16 rat liver mononuclear cells in vitro, in the presence of Recombinant Mouse SCF/c-kit Ligand (Catalog # 455-MC ), Recombinant Mouse Thrombopoietin/Tpo (Catalog # 488-TO ), and Recombinant Mouse Flt-3 Ligand (Catalog # 427-FL ). The ED50 for this effect is 0.3-1.8 ╡g/mL.

<0.10 EU per 1 ╡g of the protein by the LAL method.

Recombinant Human Angiopoietin-like 2 Protein Binding Activity

Q9UKU9.1

Bioactivity

NS0-derived Recombinant Human Angiopoietin-like 2 Protein, CF

578 USD

angiopoietin-like 2, Angiopoietin-like protein 2, angiopoietin-related protein 2, ANGPTL2, ANGRP2, ARP2HARP, MGC8889

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 3 months, -20 to -70 ░C under sterile conditions after reconstitution.